Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1128 participants
OBSERVATIONAL
2007-04-30
2011-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is conducted to administer the non-CYP3A4 metabolized statin, pitavastatin to AMI patients over 1 year, and the results will be compared with the other results from the KAMIR study which is expected to the large scale of AMI patients using statins be enrolled. Finally, from that comparison, we will investigate the influence of the statins metabolism by CYP3A4 to the therapeutic prognosis like death, major adverse cardiac events(MACE), and major ADR of statins like CK increase, myalgia.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute myocardial infarction
AMI patients who are in need to be treated by statins
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
JW Pharmaceutical
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Myung Ho Jeong
Role: PRINCIPAL_INVESTIGATOR
Chonnam National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiac and Vascular Center, Hanseo Hospital
Busan, , South Korea
Departments of Cardiology, Catholic University of Daegu College of Medicine
Daegu, , South Korea
Division of Cardiology, Department of Internal Medicine, School of Medicine, Keimyung University
Daegu, , South Korea
Division of Cardiology, Heart Center, Konyang University
Daejeon, , South Korea
Chonnam National University Hospital
Gwangju, , South Korea
Department of Cardiovascular Medicine, Wonkwang University School of Medicine
Iksan, , South Korea
Gachon University Gil Medical Center
Incheon, , South Korea
Division of Cardiology Cardiac Center, Seoul National University Bundang Hospital
Seongnam, , South Korea
Cardiovascular Center, Korea University Guro Hospital
Seoul, , South Korea
Heart Center, Division of Cardiology, Chung-Ang University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PTV-KAMI
Identifier Type: -
Identifier Source: org_study_id